Compare CP & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CP | COR |
|---|---|---|
| Founded | 1881 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.7B | 68.5B |
| IPO Year | 2000 | 2001 |
| Metric | CP | COR |
|---|---|---|
| Price | $83.25 | $351.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $92.10 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 2.6M | 934.6K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.75% | 0.68% |
| EPS Growth | ★ 13.32 | 5.71 |
| EPS | ★ 4.51 | 2.87 |
| Revenue | $15,078,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $8.21 | $8.97 |
| Revenue Next Year | $6.32 | $6.76 |
| P/E Ratio | ★ $18.61 | $122.90 |
| Revenue Growth | 3.66 | ★ 9.31 |
| 52 Week Low | $66.49 | $252.49 |
| 52 Week High | $89.42 | $377.54 |
| Indicator | CP | COR |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 42.65 |
| Support Level | $73.31 | $331.73 |
| Resistance Level | $89.42 | $353.18 |
| Average True Range (ATR) | 1.92 | 7.16 |
| MACD | -0.80 | -2.18 |
| Stochastic Oscillator | 21.04 | 6.37 |
Canadian Pacific Kansas City is a Class I railroad operating on track that spans across most of Canada and into parts of the Midwestern and Northeastern United States. Following the April 2023 Kansas City Southern merger, CPKC operates new single-linehaul services from Canada and the Upper Midwest down through Texas, the Gulf of Mexico, and into Mexico. It also hauls cross-border and intra-Mexico freight via operating concessions on more than 3,000 miles of rail in Mexico. CPKC hauls shipments of grain, intermodal containers, energy products (like crude and frac sand), chemicals, plastics, coal, fertilizer and potash, automotive products, and a diverse mix of other merchandise.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.